Empagliflozin Attenuates Pulmonary Arterial Remodeling Through Peroxisome Proliferator-Activated Receptor Gamma Activation.

The article Empagliflozin Attenuates Pulmonary Arterial Remodeling Through Peroxisome Proliferator-Activated Receptor Gamma Activation was published in ACS Pharmacology & Translational Science, 2024 August 1.

(doi: 10.1021/acsptsci.4c00127)

(SCI, IF=4.9, 30/354; Pharmacology & Pharmacy)